Material and Methods: This study expands our work reported previously which evaluated wound-healing outcomes in patients treated with a novel NPD including the focus on MMP-8 levels during treatment. In current study we measured the levels of MMP-9 and TIMP-1 in addition to MMP-8 with new patient cohorts. Thirty SCI cases with PIs of grade 4 were participated in the study. Levels of MMP-8, MMP-9 & TIMP-1 were analysed in the tissue homogenates of PIs at week 0, 3, 6 and week 9 by ELISA.
Results: The level of MMP-8 & 9 was found decreased in PIs managed with NPD at 6th week (P<0.05) which further reduced at 9th week (p=0.001). In contrast, the change in MMP-8 & 9 concentration did not reach statistical significance in PIs treated with wet to moist standard wound care. Significantly reduced surface area of NPD treated PIs was observed at week 6 (p=0.04) and at week 9 (p=0.001) as compared to standard wound care group. Similarly, significant reduction of depth was observed in NPD treated PIs at week 9 (p<0.05) and exudate became significantly (p=0.001) lower from week 6 to 9.
Conclusion: Detecting MMP-8, 9/TIMP-1 ratio on admission might be a predictor of healing. Negative pressure wound therapy is capable to balance the protease activity of the wounds.